Patients diagnosed with metastatic breast cancer have a dismal 5-year survival rate of only
24%. The RNA-binding protein Hu antigen R (HuR) is upregulated in breast cancer, and …

Controlling the selectivity of a reaction is critical for target-oriented synthesis. Accessing
complementary selectivity profiles enables divergent synthetic strategies, but is challenging …

The RNA-binding protein human antigen R (HuR) is a well-established regulator of gene
expression at the posttranscriptional level. Its dysregulation has been implicated in various …

Nearly 7.5% of all human protein-coding genes have been assigned to the class of RNA-
binding proteins (RBPs), and over the past decade, RBPs have been increasingly …

Selective access to a targeted isomer is often critical in the synthesis of biologically active
molecules. Whereas small-molecule reagents and catalysts often act with anticipated site …

Abstract The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously
expressed in human tissues, that orchestrates target RNA maturation and processing both in …

Human antigen R (HuR), also known as HuA and embryonic lethal abnormal vision-like 1
(ELAVL1), is a ubiquitously expressed RNA binding protein and functions as an RNA …

ELAV-like protein 1 or HuR (human antigen R) is an RNA-binding protein that in humans is
encoded by the ELAVL1 gene, and one of its best functions is to stabilize mRNAs in order to …

The stability of mRNA is one of the key factors governing the regulation of eukaryotic gene
expression and function. Human antigen R (HuR) is an RNA-binding protein that regulates …

Lung cancer (LC) is often diagnosed at an advanced stage and conventional treatments for
disease management have limitations associated with them. Novel therapeutic targets are …